You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Aurobindo Pharma Usa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA USA, and what generic and branded alternatives to AUROBINDO PHARMA USA drugs are available?

AUROBINDO PHARMA USA has sixty-four approved drugs.

There are two tentative approvals on AUROBINDO PHARMA USA drugs.

Summary for Aurobindo Pharma Usa

US Patents:	0
Tradenames:	55
Ingredients:	54
NDAs:	64
Patent Litigation for Aurobindo Pharma Usa:	See patent lawsuits for Aurobindo Pharma Usa
PTAB Cases with Aurobindo Pharma Usa as petitioner:	See PTAB cases with Aurobindo Pharma Usa as petitioner

Drugs and US Patents for Aurobindo Pharma Usa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Usa	TRANEXAMIC ACID	tranexamic acid	TABLET;ORAL	205133-001	Sep 21, 2015	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	QUININE SULFATE	quinine sulfate	CAPSULE;ORAL	202581-001	Dec 14, 2012		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	DOXAZOSIN MESYLATE	doxazosin mesylate	TABLET;ORAL	075509-004	Oct 19, 2000	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	040415-004	Sep 27, 2004		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	PAROXETINE HYDROCHLORIDE	paroxetine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	077873-002	Jun 29, 2007	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Aurobindo Pharma Usa	TIZANIDINE HYDROCHLORIDE	tizanidine hydrochloride	TABLET;ORAL	076282-002	Dec 16, 2003		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Aurobindo Pharma Usa

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,105,783	⤷ Sign Up
Aurobindo Pharma Usa	MAXZIDE-25	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-003	May 13, 1988	4,444,769	⤷ Sign Up
Aurobindo Pharma Usa	MAXZIDE	hydrochlorothiazide; triamterene	TABLET;ORAL	019129-001	Oct 22, 1984	4,444,769	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.